Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sonostar Ventures is a private investment firm based in New York that specializes in early-stage opportunities within the life sciences, healthcare, and technology sectors. Founded in 1991, the firm is notably recognized for its role as a foundational investor and strategic incubator for emerging biotechnology companies. A primary success for the firm was the founding and initial funding of Tonix Pharmaceuticals, where Sonostar provided the necessary capital and management to transition intellectual property into a clinical-stage pipeline. Led by Managing Member Seth Lederman, Sonostar Ventures leverages deep industry expertise to identify and develop high-potential medical assets. The firm focuses on addressing unmet medical needs in areas such as neuroscience, immunology, and infectious diseases. Through its hands-on investment approach, Sonostar Ventures continues to support the commercialization of innovative healthcare technologies and pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sonostar Ventures.